Syros Pharmaceuticals Stock (NASDAQ: SYRS)
|Day Range5.84 - 6.51||52 Wk Range5.25 - 38.5||Open / Close5.84 / 6.44||Float / Outstanding18.8M / 20.3M|
|Vol / Avg.174.4K / 207.5K||Mkt Cap130.7M||P/E-||50d Avg. Price7.95|
|Div / Yield-||Payout Ratio-||Total Float18.8M||EPS-5.4|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Syros Pharmaceuticals (NASDAQ: SYRS) through any online brokerage.
The latest price target for Syros Pharmaceuticals (NASDAQ: SYRS) was reported by Oppenheimer on Wednesday, August 10, 2022. The analyst firm set a price target for 3.00 expecting SYRS to fall to within 12 months (a possible -53.42% downside). 4 analyst firms have reported ratings in the last year.
The stock price for Syros Pharmaceuticals (NASDAQ: SYRS) is $6.44 last updated September 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for Syros Pharmaceuticals.
Syros Pharmaceuticals’s Q3 earnings are confirmed for Friday, November 4, 2022.
There is no upcoming split for Syros Pharmaceuticals.
Syros Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.